The Changing Role for Endomyocardial Biopsy in the Diagnosis of Giant-Cell Myocarditis

Ankur Kalra, Rachel Kneeland, Michael A. Samara, Leslie T. Cooper

Research output: Contribution to journalArticlepeer-review

Abstract

Endomyocardial biopsy (EMB) is central to the diagnosis of giant-cell myocarditis (GCM) and planning further management. There is, however, no guideline-directed recommendation on re-biopsy or left ventricular EMB in a suspected case of acute, fulminant myocarditis following an indeterminate first biopsy. This manuscript illustrates, with a case, the changing role for EMB in the current era in the diagnosis of GCM.

Original languageEnglish (US)
Pages (from-to)53-59
Number of pages7
JournalCardiology and Therapy
Volume3
Issue number1-2
DOIs
StatePublished - 2014

Keywords

  • Cardiology
  • Endomyocardial biopsy (EMB)
  • Giant cell
  • Left ventricular EMB
  • Myocarditis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'The Changing Role for Endomyocardial Biopsy in the Diagnosis of Giant-Cell Myocarditis'. Together they form a unique fingerprint.

Cite this